FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization. (FIT)
Phase III Study, Multivessel Percutaneous Treatment During Myocardial Infarction
Sponsor: Azienda Ospedaliera San Camillo Forlanini
Listed as NCT01160900, this PHASE3 trial focuses on Heart Failure and Ischemia and remains ongoing. Sponsored by Azienda Ospedaliera San Camillo Forlanini, it has been updated 5 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Jul 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliera San Camillo Forlanini
For direct contact, visit the study record on ClinicalTrials.gov .